|
SerentilDrug - Serentil The trade name of the product as shown on the labeling.
Dosage -
TABLET; ORAL
Active Ingredient(s) -
Mesoridazine Besylate
Strength -
EQ 100MG BASE
Applicant -
NOVARTIS
New Drug Application (NDA) Number -
016774
Product Number -
004
Therapeutic Equivalence (TE) Code -
Approval Date -
Approved Prior to Jan 1, 1982
Reference Listed Drug (RLD) -
No
Type -
DISCN
Applicant Full Name -
Novartis Pharmaceuticals Corp
Serentil
Mesna 100mg/ml Injectable; Intravenous
Mesna 100mg/ml Injectable; Intravenous Mesnex 100mg/ml Injectable; Intravenous Mesnex 400mg Tablet; Oral Serentil Eq 25mg Base/ml Concentrate; Oral Serentil Eq 25mg Base/ml Injectable; Injection Serentil Eq 100mg Base Tablet; Oral Rowasa 500mg Suppository; Rectal Asacol 400mg Tablet, Delayed Release; Oral Mesna 100mg/ml Injectable; Intravenous NewDrugInformation |